AlternativeMed
ancient wisdom · Remedy

Shugan Jieyu Capsule

Shugan Jieyu Capsule. Chinese patent medicines. For: Used for mild to moderate unipolar depression with liver depression and spleen deficiency syndrome, symptoms such as depression, decreased interest, retardation, insomnia, dreaminess, nervousness

📜 Names
Pinyin Name
Shu Gan Jie Yu Jiao Nang
中文名 (Chinese)
舒肝解郁胶囊
English Name
Shugan Jieyu Capsule
💊 Form & Use
Category
Chinese patent medicines
Dosage Form
胶囊剂 (Capsule)
Administration
Oral
Source / 出处
Chinese Pharmacopoeia 2020 edition
🌿 Composition — Clickable herb chips
🩺 Syndromes & Indications
Syndromes (中文)
舒肝解郁,健脾安神
Indications (中文)
用于轻、中度单相抑郁症属肝郁脾虚证者,症见情绪低落、兴趣下降、迟滞、失眠、多梦、紧张不安、急躁易怒、食少纳呆,胸闷,乏力,多汗,疼痛,舌苔白或腻,脉弦或细
Indications (English)
Used for mild to moderate unipolar depression with liver depression and spleen deficiency syndrome, symptoms such as depression, decreased interest, retardation, insomnia, dreaminess, nervousness, irritability, poor appetite, poor appetite, chest tightness, fatigue, and sweating , Pain, white or greasy tongue coating, stringy or thin pulse
1
Clinical Trials
12
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT05764798
Shugan Jieyu Capsule for Insomnia Patients With Depressive Symptoms
Recruiting · Phase 1 · Insomnia
📊 Sample Meta-Analyses
CRD42019115695
Efficacy and safety of oral traditional Chinese patent medicine in treatment of liver stagnation and spleen deficiency of depression: a network meta-analysis
Depression is a mental and psychological disorder that has long plagued human he
CRD42020158913
The optimization of three commonly used Chinese patent medicine in the treatment of depression of liver depression and spleen deficiency based on Bayesian network meta-analysis
Depression is a chronic and recurrent mental disorder. The main clinical charact
CRD42020164543
Network Meta-analysis of Chinese Patent Medicine Adjuvant Treatment of Post-stroke Depression
Post-stroke depression is one of the common complications of clinical cerebrovas
CRD42020195728
Comparative efficacy and acceptability of different antidepressant drugs and Chinese patent medicine for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
Major deprssive disorder (MDD) is a debilitating mental disorder characterized b
CRD42021219704
The efficacy and safety of Shugan Jieyu capsule in the treatment of essential hypertension with insomnia, anxiety or depression:A systematic review and meta-analysis
A systematic review of the clinical efficacy of Shugan Jieyu Capsule in the trea
CRD42021238804
Effectiveness of the Shugan Jieyu capsule against psychiatric symptoms in epilepsy: A protocol for systematic review and meta-analysis
Epilepsy is a chronic pathological condition of the brain that causes recurrent
📚 Sample References
None linked yet.
🏥 Indications — click any to find related diseases
🏥 Linked Health Topics 1 · matched via study conditions